.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Pioneer in Cancer Immunotherapy Receives Federal Award

Published on: October 8, 2015

AJMC Staff

Steven Rosenberg, MD, chief of surgery at NCI's Center for Cancer Research, has been awarded the 2015 Samuel J. Heyman Service to America Medal, or Sammie for his contributions to the field of immune-based cancer treatments.

The Partnership for Public Service awards Samuel J. Heyman Service to America Medal, or Sammie, to federal employees with significant contributions to the health and well-being of Americans. This year, Steven Rosenberg, MD, chief of the Surgery Branch in the National Cancer Institute's Center for Cancer Research is one of 8 federal employees to be honored this year.

Dr Rosenberg, through his research efforts, identified the important role of T cells and interleukin-2 in patients with advanced cancer who were refractory to standard treatments. Additionally, he has contributed significantly to the field of adoptive cell transfer, a procedure that engineers the patient's own T-cells to attack the tumor (also known as CAR-T cells).